Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune responses in mice

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Plasmid DNA-based immunization is a promising vaccination strategy demonstrated in animal models.
• Hepatitis C virus (HCV) presents complex structural proteins requiring effective antigen presentation for vaccine development.

Purpose of the Study:

• To evaluate immune responses to various HCV structural protein antigens using plasmid DNA immunization.
• To assess the efficacy of different plasmid constructs encoding HCV proteins as immunogens.

Main Methods:

• Construction of six recombinant plasmids encoding core, E1, E2, or combinations thereof, including a modified E2 construct.
• Transfection of plasmids into mammalian cells for protein expression analysis.
• Intramuscular injection of plasmids into BALB/c mice to measure antibody and cytotoxic T-lymphocyte (CTL) responses.

Main Results:

• All constructed plasmids demonstrated transient expression of specific HCV antigens in cells.
• Specific antibody responses against core, E1, and E2 proteins were detected in immunized mice.
• Cytotoxic T lymphocyte (CTL) responses were exclusively observed in mice receiving plasmid constructs encoding the core protein.

Conclusions:

• Genetic immunization with plasmid DNA facilitates rapid development and assessment of potential HCV vaccine immunogens.
• Plasmid DNA vaccination can elicit both humoral and cellular immune responses against HCV structural proteins.
• The core protein appears to be a key component for inducing cellular immunity in HCV DNA vaccines.